Differentiating celiac disease from other diseases: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Differentiating Celiac Disease from Other Diseases==
==Differentiating Celiac Disease from Other Diseases==
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea (diarrhea for more than 2 weeks) and abdominal pain and discomfort. The table below summarizes the findings that differentiate causes of chronic diarrhea<ref name="pmid16151544">{{cite journal| author=Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.| title=Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. | journal=Can J Gastroenterol | year= 2005 | volume= 19 Suppl A | issue=  | pages= 5A-36A | pmid=16151544 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16151544  }} </ref><ref name="pmid12135027">{{cite journal| author=Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D| title=Bowel habits and bile acid malabsorption in the months after cholecystectomy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 7 | pages= 1732-5 | pmid=12135027 | doi=10.1111/j.1572-0241.2002.05779.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12135027  }} </ref><ref name="pmid1702075">{{cite journal| author=Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R et al.| title=Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. | journal=Gastroenterology | year= 1991 | volume= 100 | issue= 2 | pages= 359-69 | pmid=1702075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1702075  }} </ref><ref name="pmid14439871">{{cite journal| author=RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC| title=Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. | journal=Gastroenterology | year= 1960 | volume= 38 | issue=  | pages= 28-49 | pmid=14439871 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14439871  }} </ref><ref name="pmid8694025">{{cite journal| author=Hertzler SR, Savaiano DA| title=Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. | journal=Am J Clin Nutr | year= 1996 | volume= 64 | issue= 2 | pages= 232-6 | pmid=8694025 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8694025  }} </ref><ref name="pmid9414969">{{cite journal| author=Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC| title=Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? | journal=Gut | year= 1997 | volume= 41 | issue= 5 | pages= 632-5 | pmid=9414969 | doi= | pmc=1891556 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9414969  }} </ref><ref name="pmid15391722">{{cite journal| author=BLACK-SCHAFFER B| title=The tinctoral demonstration of a glycoprotein in Whipple's disease. | journal=Proc Soc Exp Biol Med | year= 1949 | volume= 72 | issue= 1 | pages= 225-7 | pmid=15391722 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15391722  }} </ref>
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea (diarrhea for more than 2 weeks) and abdominal pain and discomfort. The table below summarizes the findings that differentiate causes of chronic diarrhea and abdominal pain:<ref name="pmid16151544">{{cite journal| author=Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.| title=Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. | journal=Can J Gastroenterol | year= 2005 | volume= 19 Suppl A | issue=  | pages= 5A-36A | pmid=16151544 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16151544  }} </ref><ref name="pmid12135027">{{cite journal| author=Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D| title=Bowel habits and bile acid malabsorption in the months after cholecystectomy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 7 | pages= 1732-5 | pmid=12135027 | doi=10.1111/j.1572-0241.2002.05779.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12135027  }} </ref><ref name="pmid1702075">{{cite journal| author=Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R et al.| title=Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. | journal=Gastroenterology | year= 1991 | volume= 100 | issue= 2 | pages= 359-69 | pmid=1702075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1702075  }} </ref><ref name="pmid14439871">{{cite journal| author=RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC| title=Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. | journal=Gastroenterology | year= 1960 | volume= 38 | issue=  | pages= 28-49 | pmid=14439871 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14439871  }} </ref><ref name="pmid8694025">{{cite journal| author=Hertzler SR, Savaiano DA| title=Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. | journal=Am J Clin Nutr | year= 1996 | volume= 64 | issue= 2 | pages= 232-6 | pmid=8694025 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8694025  }} </ref><ref name="pmid9414969">{{cite journal| author=Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC| title=Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? | journal=Gut | year= 1997 | volume= 41 | issue= 5 | pages= 632-5 | pmid=9414969 | doi= | pmc=1891556 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9414969  }} </ref><ref name="pmid15391722">{{cite journal| author=BLACK-SCHAFFER B| title=The tinctoral demonstration of a glycoprotein in Whipple's disease. | journal=Proc Soc Exp Biol Med | year= 1949 | volume= 72 | issue= 1 | pages= 225-7 | pmid=15391722 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15391722  }} </ref>
 
 
{| class="wikitable"
{| class="wikitable"
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause
Line 54: Line 56:
* [[Immunoglobulin A]] (IgA) anti-tissue transglutaminase (TTG) antibody
* [[Immunoglobulin A]] (IgA) anti-tissue transglutaminase (TTG) antibody
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
!Grain allergy
| +
| +
| -
| -
|Adult
|Childhood
| -
| +
| -
| +
| +
| +
|
|
* [[Abdominal tenderness]]
* Vomiting
* Abdominal distention
|
|
* Stool [[osmotic]] gap of >125 mOsm/kg 
* Elevated IgE levels
* Stool pH <6 
|
|
* Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]]
* Atopic dermatitis (eczema)
* Substitution to maintain [[nutrient]] intake
* dysphagia
* Regulation of [[calcium]] intake
* Use of [[enzyme]] [[lactase]]
|
|
* Acquired primary [[lactase deficiency]]
* Abnormal immune response to wheat [[antigens]]
** Adult-type [[hypolactasia]]
** [[Lactase]] nonpersistence)
|
|
* [[Lactose]] breath hydrogen test
* Measurement of grain-specific immunoglobulin E (IgE)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
Line 103: Line 101:
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
|-
|-
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]]
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
| +
| +
| -
| -
|After childhood
|Adult
|<nowiki>+/-</nowiki>
| -
| -
| -
| +/-
| +
|
* [[Abdominal tenderness]]
|
|
* Enhanced [[gastrointestinal]] motility and [[gastrointestinal]] sound
* Stool [[osmotic]] gap of >125 mOsm/kg 
* Mild [[abdominal tenderness]]
* Stool pH <6 
* [[Abdominal distension|Abdominal bloating]]
|
|
* [[Hypokalemia]] 
* Avoidance of [[Dietary|dietary]]<nowiki/> [[lactose]]
* [[Metabolic alkalosis]]
* Substitution to maintain [[nutrient]] intake
* [[Hypermagnesemia]](in case of [[magnesium]] [[laxative]] usage)
* Regulation of [[calcium]] intake
|<nowiki>-</nowiki>
* Use of [[enzyme]] [[lactase]]
|
|
* [[Laxative]] drug abuse
* Acquired primary [[lactase deficiency]]
** Adult-type [[hypolactasia]]
** [[Lactase]] nonpersistence)
|
|
* [[Laxatives|laxative]] screening on a stool for:
* [[Lactose]] breath hydrogen test
** [[Diphenolic laxatives]] (eg, [[bisacodyl]])
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
Line 133: Line 132:
(20th)
(20th)
| +
| +
|
|<nowiki>+/-</nowiki>
| +
| +
|
|
Line 153: Line 152:
|
|
* [[Colonoscopy]] with [[biopsy]]
* [[Colonoscopy]] with [[biopsy]]
|-
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]]
| +
| -
|After childhood
|<nowiki>+/-</nowiki>
| -
| +/-
|
* Enhanced [[gastrointestinal]] motility and [[gastrointestinal]] sound
* Mild [[abdominal tenderness]]
* [[Abdominal distension|Abdominal bloating]]
|
* [[Hypokalemia]] 
* [[Metabolic alkalosis]]
* [[Hypermagnesemia]](in case of [[magnesium]] [[laxative]] usage)
|<nowiki>-</nowiki>
|
* [[Laxative]] drug abuse
|
* [[Laxatives|Laxative]] screening on a stool for:
** [[Diphenolic laxatives]] (eg, [[bisacodyl]])
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]]
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]]
Line 180: Line 202:
|
|
* [[TSH]]  
* [[TSH]]  
|-
! align="center" style="background:#DCDCDC;" |[[Whipple's disease|Whipple disease]]
| +/-
| +
|50th
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Arthralgia|Arthralgias]] of the large joints
* [[Hematochezia]]
|
* [[Leukocytopenia]]
* [[Thrombocytopenia]]
|
* [[Skin hyperpigmentation]]
* [[Arthralgias]]
|
* ''[[Tropheryma whipplei]]''
|
* Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing
|-
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]]
| +
| -
|Between 30 and 50
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Abdominal tenderness]]
* Hard stool in the rectal vault
|<nowiki>-</nowiki>
|
* [[Bloating|Bloating]]
* [[Flatulence]]
|
* Postinfectious
* Inflammatory
|
* [[Diagnosis|Clinical diagnosis]]
** ROME III criteria
** [[Pharmacological|Pharmacologic]] studies based criteria
|-
|-
! align="center" style="background:#DCDCDC;" |[[VIPoma]]
! align="center" style="background:#DCDCDC;" |[[VIPoma]]
Line 210: Line 275:
* Followed by imaging
* Followed by imaging
|-
|-
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]]
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]])
| +
| +
| -
| -
|Between 30 and 50
|Between the ages of 20 and 50
|<nowiki>-</nowiki>
| +
|<nowiki>-</nowiki>
| +/-
|<nowiki>+</nowiki>
| +
|
* Mild to moderate upper [[abdominal tenderness]]
|
|
* [[Abdominal tenderness]]
* Positive [[secretin]] stimulation test
* Hard stool in the rectal vault
* Elevated serum [[chromogranin A]]
|<nowiki>-</nowiki>
|
|
* [[Bloating|Bloating]]
* [[Heartburn]]
* [[Flatulence]]
|
|
* Postinfectious
* [[Gastrin]] producing tumor mainly in [[duodenum]]
* Inflammatory
|
|
* [[Diagnosis|Clinical diagnosis]]
* Elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL
** ROME III criteria
** [[Pharmacological|Pharmacologic]] studies based criteria
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
Line 254: Line 316:
* Reduction of lactase enzyme activity or lactase nonpersistence
* Reduction of lactase enzyme activity or lactase nonpersistence
* Congenital lactase deficiency
* Congenital lactase deficiency
|Lactase activity assay
|-
! align="center" style="background:#DCDCDC;" |[[Whipple's disease|Whipple disease]]
| +/-
| +
|50th
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Arthralgia|Arthralgias]] of the large joints
* [[Hematochezia]]
|
|
* [[Leukocytopenia]]
* Lactase activity assay
* [[Thrombocytopenia]]
|
* [[Skin hyperpigmentation]]
* [[Arthralgias]]
|''[[Tropheryma whipplei]]'' 
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]])
|-
|-
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
Line 292: Line 336:
* Triggered by cow's milk protein
* Triggered by cow's milk protein
* Profuse, repetitive [[vomiting]]
* Profuse, repetitive [[vomiting]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|
|[[Oral]] food challenge (OFC)
* [[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|
* [[Oral]] food challenge (OFC)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
Line 312: Line 358:
* One-half of patients have other [[Allergic disorders|allergic diseases]]
* One-half of patients have other [[Allergic disorders|allergic diseases]]
* Associated with an identifiable [[dietary]] [[antigen]]
* Associated with an identifiable [[dietary]] [[antigen]]
|[[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|
|[[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
* [[Autoimmunity|Autoimmune]]/[[Allergy|allergic]] response to food [[antigens]]
|
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
|-
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption
| +
| +/-
|Childhood Adolescents
| +
| +
| +/-
| -
|
* Low  [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K
* [[Anemia]]
|
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
|
* [[Genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
|
* Total and specific [[bile acid]]<nowiki/>s from stool
* [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT)
|-
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]]
| -
| +
|Infancy
| +
| +
| +
|
* [[Abdominal distension|Abdominal distention]]
* Impaired [[visual acuity]] and [[Visual field defect|visual field defects]]
* [[Dysarthria]]
|
* Low [[triglyceride]]
* Low total [[cholesterol]] levels 
* [[Acanthocytes]]
* Low [[vitamin E]] levels
|
* [[Clumsiness]]
* Vision impairment
* [[Ataxia]]
|
* [[Autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
|
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
|-
|-
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
Line 391: Line 483:
| +/-
| +/-
| +
| +
|[[Abdominal tenderness]]
|
* [[Abdominal tenderness]]
|[[Stool examination|Stool examination:]]
|[[Stool examination|Stool examination:]]
* Acidic
* Acidic
Line 403: Line 496:
|
|
* Positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]]
* Positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]]
|-
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]]
| -
| +
|Infancy
| +
| +
| +
|
* [[Abdominal distension|Abdominal distention]]
* Impaired [[visual acuity]] and [[Visual field defect|visual field defects]]
* [[Dysarthria]]
|
* Low [[triglyceride]]
* Low total [[cholesterol]] levels 
* [[Acanthocytes]]
* Low [[vitamin E]] levels
|
* [[Clumsiness]]
* Vision impairment
* [[Ataxia]]
|
* [[Autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
|
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
|-
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption
| +
| +/-
|Childhood Adolescents
| +
| +
| +/-
| -
|
* Low  [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K
* [[Anemia]]
|
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
|
* [[Genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
|
* Total and specific [[bile acid]]<nowiki/>s from stool
* [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT)
|-
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]<nowiki/>)
| +
| -
|Between the ages of 20 and 50
| +
| +/-
| +
|
* Mild to moderate upper [[abdominal tenderness]]
|
* Positive [[secretin]] stimulation test
* Elevated serum [[chromogranin A]]
|
* [[Heartburn]]
|
* [[Gastrin]] producing tumor mainly in [[duodenum]]
|
* Elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL
|}
|}



Revision as of 14:53, 13 September 2017

Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating celiac disease from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating celiac disease from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating celiac disease from other diseases

CDC on Differentiating celiac disease from other diseases

Differentiating celiac disease from other diseases in the news

Blogs onDifferentiating celiac disease from other diseases

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Differentiating celiac disease from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. Common differntials of celiac disease include lactose intolerance, cystic fibrosis, Crohns disease, laxative overuse, hyperthyroidism and irritable bowel syndrome.

Differentiating Celiac Disease from Other Diseases

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea (diarrhea for more than 2 weeks) and abdominal pain and discomfort. The table below summarizes the findings that differentiate causes of chronic diarrhea and abdominal pain:[1][2][3][4][5][6][7]


Cause Diarrhea Peak age of onset History Physical exam Lab findings Additional finding Cause/Pathogenesis Gold standard dignosis
Watery Fatty Weight loss FTT Abdominal pain
Celiac disease +/- +/- Childhood

Adult

+ + +
Grain allergy + - Childhood + + +
  • Vomiting
  • Abdominal distention
  • Elevated IgE levels
  • Atopic dermatitis (eczema)
  • dysphagia
  • Abnormal immune response to wheat antigens
  • Measurement of grain-specific immunoglobulin E (IgE)
Cystic fibrosis - + Infancy and childhood + + +
  • Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Lactose intolerance + - Adult - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Crohns disease + - Young adults

(20th)

+ +/- +
  • Abnormal immune response to self antigens
Laxative overuse + - After childhood +/- - +/- -
Hyperthyroidism + - Any age + - +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
Whipple disease +/- + 50th + - +
Irritable bowel syndrome + - Between 30 and 50 - - + -
  • Postinfectious
  • Inflammatory
VIPoma + - Between 30 and 50 + +/- +/-
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Gastrinoma (Zollinger-Ellison syndrome) + - Between the ages of 20 and 50 + +/- +
  • Elevated basal or stimulated serum gastrin more than 1000 pg/mL
Lactose intolerance - + Any age + - +/-
  • Reduction of lactase enzyme activity or lactase nonpersistence
  • Congenital lactase deficiency
  • Lactase activity assay
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) + - Infancy +/- +/- + Stool examination:
  • Triggered by cow's milk protein
  • Profuse, repetitive vomiting
  • Oral food challenge (OFC)
Eosinophilic gastroenteritis  + - 30th +/- +/- +
Primary bile acid malabsorption + +/- Childhood Adolescents + + +/- -
Abetalipoproteinemia - + Infancy + + +
Microscopic colitis + - 60th + - +
Congenital chloride diarrhea + - Neonate + + - -

Mutations in the SLC26A3 gene

Congenital sodium diarrhea + - Neonate + + - - Stool examination:

Serum:

  • Mutations in the SPINT2 gene
Clinical
Glucose-galactose malabsorption + - Infancy + +/- + Stool examination:
  • Acidic
  • Mutations in solute carrier family 5, member 1 gene (SLC5A1, also known as SGLT1)
    • Lead to deficiency in the intestinal sodium/glucose transporter

References

  1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  2. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  3. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
  4. RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
  5. Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  6. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  7. BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

Template:WH Template:WS